14 - 17 Nov 2022 | Las Vegas

Moving the Needle on Commercial Reimbursement

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

About this Session:

One of the key ongoing challenges that DTx faces is attaining coverage from payors; during our first session, we hope to shed light on what payors are looking for clinically and economically (hint: it's evidence). Moderator: Jessica Hauflaire , COO, Digital Therapeutics Alliance Panelists: Julia Strandberg , Chief Commercial Officer, Pear Therapeutics Joe Perekupka , CEO, Freespira  Jason Parent , Director, Clinical Innovation, Point32Health